表 1. Comparison of the baseline data of the three groups of CIS patients in the study.
Baseline data | Regular treatment group (n=31) | LF-rTMS group (n=31) | Combinatin treatment group (n=31) | F/χ2 | P |
Gender/case (%) | χ2=0.784 | 0.657 | |||
Male | 20 (64.52) | 17 (54.84) | 16 (51.61) | ||
Female | 11 (35.48) | 14 (45.16) | 15 (48.39) | ||
Age/yr. | 55.42±7.25 | 56.24±7.37 | 57.32±7.47 | F=0.776 | 0.652 |
Disease course/h | 25.12±4.34 | 25.36±4.69 | 26.45±5.14 | F=0.845 | 0.624 |
Infarction area/case (%) | χ2=0.785 | 0.657 | |||
Basal ganglia | 17 (54.84) | 16 (51.61) | 15 (48.39) | ||
Frontal lobe | 7 (22.58) | 8 (25.81) | 10 (32.26) | ||
Temporal lobe | 4 (12.90) | 5 (16.13) | 4 (12.90) | ||
Brain stem | 3 (9.68) | 2 (6.45) | 2 (6.45) | ||
Comorbidity/case (%) | |||||
Hypertension | 7 (22.58) | 8 (25.81) | 9 (29.03) | χ2=0.562 | 0.924 |
Diabests | 3 (9.68) | 5 (16.13) | 6 (19.35) | χ2=0.812 | 0.643 |